The Indirect Impact of COVID‐19 Pandemic on Mortality, Complications, and Healthcare Utilization Among Patients With Chronic Respiratory Diseases in Hong Kong: An Interrupted Time Series Analysis
The disruption of usual healthcare impacts mortality rates among patients with CRD without COVID-19, particularly nonrespiratory mortality. Contingency plans on continuing follow-up and monitoring of CRD patients are needed, for example, teleconsultations, shared primary care, and tele-reminders on red-flag symptoms for patients with CRD, when healthcare services may be disrupted during public health crises.
Authors
- Chak Sing Lau (ORCID: https://orcid.org/0000-0001-6698-8355)
- Yuk Kam Yau (ORCID: https://orcid.org/0000-0003-2865-5992)
- Cindy Lo Kuen Lam (ORCID: https://orcid.org/0000-0001-7536-8481)
- Eric Yuk Fai Wan (ORCID: https://orcid.org/0000-0002-6275-1147)
- Jianchao Quan (ORCID: https://orcid.org/0000-0002-8386-8512)
- David Vai Kiong Chao (ORCID: https://orcid.org/0000-0001-7120-5597)
- Ivy Lynn Mak (ORCID: https://orcid.org/0000-0002-6685-6659)
- Ian Chi Kei Wong (ORCID: https://orcid.org/0000-0001-8242-0014)
- Zhuoran Hu (ORCID: https://orcid.org/0000-0002-6398-9229)
- Qi Kang (ORCID: https://orcid.org/0000-0002-4088-2760)
- David Chi Leung Lam
- Welchie Wai Kit Ko
Institutions
- Hospital Authority (HK)
- Aston University (GB)
- Chinese University of Hong Kong (HK)
- United Christian Hospital (CN)
- Institute for Advanced Study (DE)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Journal of Evidence-Based Medicine
- Published
- 2025-05-29
- DOI
- https://doi.org/10.1111/jebm.70039
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Pfizer
- World Health Organization
- European Commission
- National Natural Science Foundation of China
- Hong Kong Government
- Medical Research Council
- National Health and Medical Research Council
- Health and Medical Research Fund